This is the third in a three-part series by Dr. Heather Buschman on Big Data in the pharmaceutical and biotechnology industries. Check out…

This is the second in a three-part series by Dr. Heather Buschman on Big Data in the pharmaceutical and biotechnology industries. Check out…

Luke Timmerman recently posted a nice blog at Xconomy talking about the poor public perception of the pharmaceutical industry and what the industry…

With the Big Data Science Innovation Summit 1 happening next month here in San Diego, we invited Dr. Heather Buschman to share current views on Big…

The need for CNS therapeutics is on the rise.  Neurological diseases are expected to increase steadily in the coming years.  Previously, we addressed…